Alcaraz Hits 34¢ on Polymarket as Sinner and Djokovic Exit the Picture

Carlos Alcaraz stepped back onto a Grand Slam court after 139 days away and looked, by most accounts, like someone who had never left. The prediction market noticed.

TL;DR

Alcaraz's Polymarket contract climbed from 26¢ on August 21 to 34¢ on September 1 — an 8-cent move in 11 days driven by his dominant first-round return and the exits of Sinner and Djokovic.
World No. 1 Jannik Sinner withdrew from the tournament with a right knee injury; fourth-seeded Novak Djokovic lost in the first round to Mariano Navone on August 31.
Alcaraz dismantled Roman Safiullin 6-3, 6-4, 6-2 with 28 winners in his first match since mid-April, wearing only a compression sleeve on his right wrist.
At 34¢ YES and -250 in sports-book odds, the gap between market caution and book confidence reflects a simple question: is the wrist really fine, or are traders right to hedge?

What the Market Says

We covered this market earlier. Our last logged price was 26¢ YES on August 21 — a figure that reflected legitimate anxiety about a defending champion who had not struck a competitive ball since mid-April. As of September 1 at 11:07 UTC, the contract sits at 34¢ YES / 66¢ NO on Polymarket, with 24-hour volume of $146,063 and a one-day move of +4¢. The 11-day cumulative shift is +8¢.

The sportsbooks are less conflicted. Alcaraz is priced at -250 (roughly 27% implied probability) at major books, while Alexander Zverev — the top seed and reigning French Open champion — comes in at +300 (roughly 25% implied). On Polymarket, Zverev sits at 24¢. The gap between Alcaraz's 34¢ on Polymarket and his -250 book line is not irrational noise; it is a structured disagreement about injury trajectory. The books are saying the wrist is fine. A meaningful portion of Polymarket traders are saying: let's see a few more matches first.

That is a defensible position. It is also, after Sunday's result, a position that is eroding by the day.

The Case

The threat landscape for Alcaraz entering this tournament looked genuinely cluttered ten days ago. Jannik Sinner — the world No. 1, Alcaraz's most dangerous peer, and a player who had been at 0¢ in Polymarket's parallel Sinner contract since August 22 — was already priced out. But Djokovic, seeded fourth and chasing a 25th Grand Slam title, remained a credible obstacle.

He is no longer one. Djokovic fell in the first round on August 31 to Argentina's Mariano Navone — a result RotoWire described in the context of Djokovic not having won a match since a five-set Wimbledon quarterfinal against Auger-Aliassime. Whatever version of Djokovic arrived in New York, it was not the version that wins majors. He is out.

Into this clearing stepped Alcaraz, who responded to 139 days of inactivity by producing 28 winners against Safiullin in a 6-3, 6-4, 6-2 win. BBC Sport reported that his trademark forehand — the whippy, inside-out stroke that has defined his game since he was a teenager — accounted for the bulk of those winners despite the compression sleeve on his right arm. His post-match remarks were measured, not triumphant, which is probably the more honest signal:

"I felt great. I don't know how it looked from outside, but from inside, my feeling was that I was hitting normal. I was playing pretty style, and everything felt great."

He also acknowledged the gap between one good match and full tournament readiness:

"There were some doubts in the match, I'm not going to lie. But I need more matches under the belt to get again into the rhythm of the tournament. I'm pretty sure I'm going to get better and better every day."

That last line is the crux of the bull case. A 23-year-old with seven Grand Slam titles, restored to something close to full health, improving with each passing round in a draw that has just lost its two most formidable occupants — that is a profile worth 34¢, and possibly more.

RotoWire's preview reinforces the structural argument: Alcaraz, seeded second, faces only one top-10 player — eighth-seeded Ben Shelton — before the semifinals. The analysis is blunt: "There is no doubt Alcaraz is capable of navigating his tricky early draw if he's back to full health, even after his multi-month layoff, and the seven-time Grand Slam champion's A-game is clearly better than what anybody else in this tournament can currently produce in Sinner's absence."

That is a high bar to clear, but Alcaraz's ceiling in a hardcourt major has been demonstrated repeatedly. The question was always fitness, not talent.

Risks

The serve numbers from Sunday deserve honest attention. Alcaraz recorded 2 aces and 5 double faults against Safiullin — a man ranked well outside the top 10. He offered a tactical explanation for the serve conservatism, but double faults at that rate become expensive against Shelton, who punishes second balls aggressively, or against any top-half contender who reaches the quarterfinal.

Alcaraz also admitted, without much prompting, that he had genuine doubts before and during the Safiullin match about whether he could sustain five-set intensity. One three-set win over a lower-ranked opponent, while encouraging, does not settle that question. Three more rounds to the final require four or five consecutive convincing performances against opponents who will be fresher, better-prepared, and specifically targeting a wrist that spent most of the summer immobilized. If the compression sleeve graduates to something more serious, the 34¢ compresses fast.

The draw also presents a structural risk on the other side of the bracket. Zverev — currently at 24¢ on Polymarket and +300 at the books — is playing in a half of the draw that, per RotoWire, contains most of the remaining contenders. His path to the final is relatively unobstructed. A Zverev-Alcaraz final is entirely plausible, and in a final on hardcourt, Zverev's serve and forehand power make him a genuine test even for a fully healthy Alcaraz.

Beyond Zverev, two sleepers merit tracking: Ben Shelton (No. 8 seed, fresh off the Canadian Open title) and Arthur Fils (No. 10 seed, Cincinnati Open champion). Both are in form, both are capable of winning five-set matches, and both would pose specific tactical problems — Shelton with his explosive left-handed serve and Fils with his defensive retrieval. If Alcaraz's wrist flares or his serve fails to stabilize, either of these players becomes a live upset candidate.

The 66¢ NO position is not irrational. It is simply the view that one match, against one opponent, in three sets, does not fully resolve a 139-day injury question. That view has a price, and right now it is priced at roughly two-to-one against Alcaraz winning the whole tournament.

The 8-cent move in 11 days is the market updating on real information: a player who looked like a question mark is now a player who dismantled someone in straight sets and walked off saying he felt great. The threat landscape thinned dramatically over the same 11 days. The caution baked into 34¢ is not about talent or draw — it is about whether four more rounds will tell the same story as round one.

So far, the story reads well.

Prices captured at press time and are not live. Not financial advice. Independent publication - not affiliated with Polymarket, Banana Gun, or any venue.